Cardiac Rehabilitation Maintenance Programs for Cardiovascular Disease
(EMPOWER ME Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which cardiac rehabilitation maintenance programs are most effective for individuals who have recently completed a cardiac rehab program. It will test various methods, including text messaging, a fully automated online program, and different levels of rehab intensity, to identify which approach helps participants maintain healthy habits with minimal hassle. Participants must have completed at least six cardiac rehab sessions recently and belong to specific groups, such as identifying as a woman, LGBTQIA+, or experiencing difficulty with healthcare access. As an unphased trial, this study provides a unique opportunity to explore innovative rehab methods tailored to diverse groups.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the treatments in this study are generally safe for individuals with heart conditions. The fully automated online program, a type of digital cardiac rehabilitation, does not increase the risk of serious issues and helps maintain healthy habits.
The high-intensity cardiac rehabilitation program is safe and well-tolerated for those with heart problems, matching the safety of moderate-intensity exercises commonly used in cardiac rehab.
The low-intensity cardiac rehabilitation program is also safe. Studies have demonstrated its low risk of complications, making it a reliable way to improve heart health.
Using text messages as a support tool in cardiac rehab is both safe and practical. It aids in managing heart health by reminding individuals to adhere to healthy habits.
Overall, these treatments are well-tolerated and support heart health without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to maintain heart health after cardiac rehabilitation. Unlike traditional cardiac rehab programs, which often rely on in-person sessions, this trial leverages digital tools like text messaging and online programs to encourage healthy behaviors. The fully automated online program stands out by providing tailored lessons and feedback based on self-monitoring data, making it highly personalized. Additionally, the integration of low- and high-intensity maintenance programs, supported by resources and virtual meetings, aims to sustain the benefits of rehab long-term. This approach could revolutionize how heart health is maintained, making it more accessible and adaptable to individual needs.
What evidence suggests that this trial's treatments could be effective for cardiovascular disease?
This trial will compare various cardiac rehabilitation maintenance programs for cardiovascular disease. Research has shown that the Fully Automated Online Program, one of the interventions in this trial, can help improve exercise capacity and adherence to rehab routines. Studies have found that digital heart rehab programs can enhance patient happiness and increase exercise adherence. Evidence suggests that the High-Intensity Cardiac Rehabilitation Maintenance Program, another intervention in this trial, can improve heart and lung fitness more effectively than moderate-intensity programs. The Low-Intensity Cardiac Rehabilitation, also being tested, has been shown to lower death rates and improve the quality of life for people with heart disease. Finally, text messaging, another intervention option, has increased physical activity and medication adherence, proving useful for managing heart disease.23467
Are You a Good Fit for This Trial?
This trial is for individuals finishing or soon to finish cardiac rehabilitation, particularly those from underrepresented groups in cardiac rehab research, with limited access to maintenance programs, or who may benefit from extra support post-rehab. Participants must meet certain health criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Intervention
Participants receive either a low-intensity text messaging intervention or a fully automated online program for 2 months
Second Intervention
Non-responders to the initial intervention receive either low-intensity or high-intensity home-based cardiac rehabilitation for 3 months
Follow-up
Participants are monitored for adherence to cardioprotective behaviors and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Fully Automated Online Program
- High Intensity Cardiac Rehabilitation Maintenance Program
- Low-Intensity Cardiac Rehabilitation Maintenance Program
- Text Messaging
Trial Overview
The study compares low-intensity vs. high-intensity cardiac rehabilitation maintenance programs after outpatient rehab ends. It also tests text messaging and a fully automated online program to see which approach best maintains health improvements with minimal burden.
How Is the Trial Designed?
6
Treatment groups
Experimental Treatment
Participants receive the text messaging intervention for 2 months. Following their mid-intervention assessment, they are randomized to receive the low-intensity cardiac rehabilitation maintenance program. Patients are instructed to log in 3 times weekly to view lessons, sync their Fitbit data, and complete a home-based workout video. They track weight, PA, and medication adherence daily. Patients have access to an extensive CR resource library made and curated by the platform provider plus resources on maintaining heart healthy behaviors during Phase III created by the research team. They are reminded to log in if they log in less than twice weekly.
Participants receive the text messaging intervention for 2 months. Following their mid-intervention assessment, they are randomized to receive the high-intensity cardiac rehabilitation maintenance program. Patients are instructed to log in 3 times weekly to view lessons, sync their Fitbit data, and complete a home-based workout video. They track weight, PA, and medication adherence daily and attend a once weekly virtual meeting with a CR case manager. Meetings are modeled after Phase II and focus on tailored exercise prescription, addressing cognitive, behavioral, and environmental adherence barriers, and support. Patients have access to an extensive CR resource library made and curated by the platform provider plus resources on maintaining heart healthy behaviors during Phase III created by the research team. They are reminded to log in if they log in less than twice weekly.
Participants are first randomized to the low-intensity text messaging intervention. On 3 days/week they receive a text about 1 of the 3 behaviors (weight maintenance or loss, physical activity, and medication adherence) in randomized order with guidance for maintaining or improving these behaviors to reach program-provided goals. The system compares their last week's adherence to the responder criteria. They receive feedback praising adherence and instructions for a theory-driven behavioral strategy (e.g., stimulus control) to increase adherence. Feedback is tailored to the patient's adherence or existence of self-monitoring data. Participants meeting responder criteria after 2 months will continue to receive the text messaging intervention for the next 3 months.
Patients receiving the fully automated online program will select a weight loss or a weight maintenance curriculum based on their goals. Patients will receive 8 weeks of fully automated lessons covering the 3 key behaviors: weight (management or loss), physical activity, and medication adherence. All 3 behaviors are discussed weekly, but the lessons first prioritize PA, then weight management, and then medication adherence to mimic the emphasis in Phase II. Total weekly lesson time is 20-30 minutes. Patients retain access to lessons. They self-monitor calories, weight, moderate-to-vigorous physical activity, and medication adherence. Tracking data are seamlessly integrated into the system. They manually enter their medication adherence data and receive encouraging feedback on each of the behaviors the next week. Participants meeting responder criteria after 2 months will continue to receive the fully automated online program.
Participants receive the fully automated online program for 2 months. Following their mid-intervention assessment, they are randomized to receive the low-intensity cardiac rehabilitation maintenance program. Patients are instructed to log in 3 times weekly to view lessons, sync their Fitbit data, and complete a home-based workout video. They track weight, PA, and medication adherence daily. Patients have access to an extensive CR resource library made and curated by the platform provider plus resources on maintaining heart healthy behaviors during Phase III created by the research team. They are reminded to log in if they log in less than twice weekly.
Participants receive the fully automated online program intervention for 2 months. Following their mid-intervention assessment, they are randomized to receive the high-intensity cardiac rehabilitation maintenance program. Patients are instructed to log in 3 times weekly to view lessons, sync their Fitbit data, and complete a home-based workout video. They track weight, PA, and medication adherence daily and attend a once weekly virtual meeting with a CR case manager. Meetings are modeled after Phase II and focus on tailored exercise prescription, addressing cognitive, behavioral, and environmental adherence barriers, and support. Patients have access to an extensive CR resource library made and curated by the platform provider plus resources on maintaining heart healthy behaviors during Phase III created by the research team. They are reminded to log in (after they miss a login) if they log in less than twice weekly.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Office of the Director, National Institutes of Health (OD)
Collaborator
Published Research Related to This Trial
Citations
Long-Term Outcomes of Digital Cardiac Rehabilitation
The review examines critical factors that influence the success of digital CR, such as digital literacy, concerns about data security, adherence to digital ...
Effectiveness of home-based cardiac rehabilitation ...
This study aims to assess the effects of mHealth HBCR interventions compared with usual care and CBCR in patients with heart disease.
Digital Technologies in Cardiac Rehabilitation: A Science ...
This American Heart Association science advisory was assembled to guide the development and implementation of digital cardiac rehabilitation interventions.
Effectiveness of Home-Based Cardiac Rehabilitation ...
A 6-week home-based CR program with exercise readjustment using a mobile app can potentially enhance exercise capacity as effectively as verbal supervision.
Real-World Evaluation of a Digitally Enabled Cardiac ...
The Investigators aim to assess a digitally enabled cardiac rehabilitation (DeCR) program, called Heart Health at Home, implemented in a real-world setting. The ...
Safety and long-term outcomes of remote cardiac ...
To systematically review the safety and the long-term mortality and morbidity risk-rates of the remotely-delivered cardiac rehabilitation ...
A Dual-Modality Home-Based Cardiac Rehabilitation Program ...
Background: Cardiac rehabilitation (CR) is a safe, effective intervention for individuals with cardiovascular disease (CVD).
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.